1.
Remacha AF, Arrizabalaga B, Bueno J, Muñoz J, Bargay J, Pedro C. Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment. Haematologica 2010; 95(2):339-340; https://doi.org/10.3324/haematol.2009.016956.